News Features Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too Michael O'Riordan December 09, 2019
News Daily News Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe Yael L. Maxwell October 16, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Conference News TCT 2019 Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III Michael O'Riordan October 03, 2019
News Conference News TCT 2019 Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE Michael O'Riordan September 30, 2019
News Conference News ESC 2019 For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI Todd Neale September 03, 2019
News Daily News Hybrid Revascularization for Multivessel CAD Rarely Used in the US Todd Neale July 04, 2019
News Daily News Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI? Michael O'Riordan July 03, 2019
News Conference News SCAI 2019 Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib Yael L. Maxwell May 24, 2019
News Conference News EuroPCR 2019 Long-term Ticagrelor Monotherapy May Have an Edge in Complex PCI Patients: GLOBAL LEADERS Michael O'Riordan May 21, 2019
News Daily News Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure? Yael L. Maxwell May 15, 2019
News Conference News ACC 2019 Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY Yael L. Maxwell March 27, 2019
News Daily News ‘Striking’ Improvements in Acute MI Care Over Past 20 Years, Report Shows Michael O'Riordan March 19, 2019
News Daily News The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients L.A. McKeown February 26, 2019